Summary
A major challenge to contemporary peptide chemistry is to reproduce highly complex active sites or complexes of native proteins. In addition to the need for the combination of different peptide fragments, true protein mimics designed for therapeutic use frequently require the incorporation of multiple copies of given active domains in a biologically relevant spatial arrangement. Perhaps the best examples for this line of drug design are subunit vaccine candidates against extracellular domains of ion-channel proteins. One of our earlier constructs containing four copies of the ectodomain of the M2 protein of influenza virus together with two independent T-helper cell epitopes induced protective antibody production in mice. Here I describe an improved synthesis of the M2-based multiepitope and multivalent peptide construct. In general, the synthetic strategy outlined here can serve as a model for the orthogonal N-terminal and side-chain–protecting scheme during the preparation of large, complex peptides or small, engineered proteins.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Jiang, S., and Debnath, A.K. (2000) Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41. Biochem. Biophys. Res. Commun. 269, 641–646.
Rojanasakul, Y., Luo, Q., Ye, J., Antonini, J., and Toledo, D. (2000) Cellular delivery of functional peptides to block cytokine gene expression. J. Control. Rel. 65, 13–17.
Otvos, L. Jr. (2005) Antibacterial peptides and proteins with multiple cellular targets. J. Pept. Sci. 11, 697–706.
Dietzschold, B., Gore, M., Marchandiar, D., et al. (1990) Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. J. Virol. 64, 3804–3809.
Hsu, S.C., Chargelegue, D., Obeid, O.E., and Steward, M.W. (1999) Synergistic effect of immunization with a peptide cocktail inducing antibody, helper and cytotoxic T-cell responses on protection against respiratory syncytial virus. J. Gen. Virol. 80, 1401–1405.
Meyer, D., and Torres, J.V. (1999) Hypervariable epitope construct: a synthetic immunogen that overcomes MHC restriction of antigen presentation. Mol. Immunol. 36, 631–637.
Triozzi, P.L., Stoner, G.D., and Kaumaya, P.T. (1995) Subunit peptide cancer vaccines targeting activating mutations of the p21 ras proto-oncogene. Biomed. Pept. Proteins Nucleic Acids 1, 185–192.
Fitzmaurice, C.J., Brown, L.E., Kronin, K., and Jackson, D.C. (2000) The geometry of synthetic peptide-based immunogens affects the efficiency of T cell stimulation by professional antigen-presenting cells. Int. Immunol. 12, 527–535.
Cruz, L.J., Quintana, D., Iglesias, E., et al. (2000) Immunogenicity comparison of a multi-antigenic peptide bearing V3 sequences of the human immunodeficiency virus type 1 with TAB9 protein in mice. J. Pept. Sci. 6, 217–224.
Tam, J. (1988) Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci. USA 85, 5409–5413.
Wang, J., Kim, S., Kovacs, F., and Cross, T.A. (2001) Structure of the transmembrane region of the M2 protein H(+) channel. Protein Sci. 10, 2241–2250.
Shih, F.F., Cerasoli, D.M., and Caton, A.J. (1997) A major T cell determinant from the influenza virus hemagglutinin (HA) can be a cryptic self peptide in HA transgenic mice. Int. Immunol. 9, 249–261.
Kragol, G., Otvos, L., Jr., Feng, J., Gerhard, W., and Wade, J.D. (2001) Synthesis of a disulfide-linked octameric peptide construct carrying three different antigenic determinants. Bioorg. Med. Chem. Lett. 11, 1417–1420.
Mozdzanowska, K., Feng, J., Eid, M., et al. (2003) Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine 21, 2616–2626.
Zhang, M., Zharikova, D., Mozdzanowska, K., Otvos, L., Jr., and Gerhard, W. (2006) Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus. Mol. Immunol. 43, 2195–2206.
Zharikova, D., Mozdzanowska, K., Feng, J., Zhang, M., and Gerhard, W. (2005) Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2. J. Virol. 79, 6644–6654.
Pawlak, M., Meseth, U., Dhanapal. B., Mutter, M., and Vogel, H. (1994) Template-assembled melittin: Structural and functional characterization of a designed, synthetic channel-forming protein. Protein Sci. 3, 1788–1805.
Wade, J.D., Beford, J., Sheppard, R.C., and Tregear, G.W. (1991) DBU as an N-alpha-deprotecting reagent for the fluorenylmethoxycarbonyl group in continuous flow solid-phase peptide synthesis. Pept. Res. 4, 194–199.
Kragol, G., and Otvos, L., Jr. (2001) Orthogonal solid-phase synthesis of tetramannosylated peptide constructs carrying three independent branched epitopes. Tetrahedron 57, 957–966.
Palasek, S.A., Cox, Z.J., and Collins, J.M. (2007) Limiting racemization and aspartimide formation in microwave-enhanced Fmoc solid phase peptide synthesis. J. Pept. Sci. 13, 143–148.
Angell, Y.M., Garcia-Echeverria, C., and Rich, D.H. (1994) Comparative studies of the coupling of N-methylated sterically hindered amino acids during solid-phase peptide synthesis. Tetrahedron Lett. 35, 5891–5894.
Rohwedder, B., Mutti, Y., Dumy, P., and Mutter, M. (1998) Hydrazinolysis of Dde: Complete orthogonality with Aloc protecting groups. Tetrahedron Lett. 39, 1175–1178.
Spivey, A.C., and Maddaford, A. (1999) Synthetic methods part (v): Protecting groups. Annu Rep. Prog. Chem. Sect. B. 95, 83–95.
Taniguchi, T., and Ogasawara, K. Facile and specific nickel-catalyzed D-N-allylation. Tetrahedron Lett. 39, 4679–4682.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Otvos, L. (2008). Synthesis of a Multivalent, Multiepitope Vaccine Construct. In: Otvos, L. (eds) Peptide-Based Drug Design. Methods In Molecular Biology™, vol 494. Humana Press. https://doi.org/10.1007/978-1-59745-419-3_15
Download citation
DOI: https://doi.org/10.1007/978-1-59745-419-3_15
Publisher Name: Humana Press
Print ISBN: 978-1-58829-990-1
Online ISBN: 978-1-59745-419-3
eBook Packages: Springer Protocols